2g1q

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="2g1q" size="450" color="white" frame="true" align="right" spinBox="true" caption="2g1q, resolution 2.51&Aring;" /> '''crystal structure o...)
Line 1: Line 1:
-
[[Image:2g1q.gif|left|200px]]<br />
+
[[Image:2g1q.gif|left|200px]]<br /><applet load="2g1q" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="2g1q" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="2g1q, resolution 2.51&Aring;" />
caption="2g1q, resolution 2.51&Aring;" />
'''crystal structure of KSP in complex with inhibitor 9h'''<br />
'''crystal structure of KSP in complex with inhibitor 9h'''<br />
==Overview==
==Overview==
-
Molecular modeling in combination with X-ray crystallographic information, was employed to identify a region of the kinesin spindle protein (KSP), binding site not fully utilized by our first generation inhibitors. We, discovered that by appending a propylamine substituent at the C5 carbon of, a dihydropyrazole core, we could effectively fill this unoccupied region, of space and engage in a hydrogen-bonding interaction with the enzyme, backbone. This change led to a second generation compound with increased, potency, a 400-fold enhancement in aqueous solubility at pH 4, and, improved dog pharmacokinetics relative to the first generation compound.
+
Molecular modeling in combination with X-ray crystallographic information was employed to identify a region of the kinesin spindle protein (KSP) binding site not fully utilized by our first generation inhibitors. We discovered that by appending a propylamine substituent at the C5 carbon of a dihydropyrazole core, we could effectively fill this unoccupied region of space and engage in a hydrogen-bonding interaction with the enzyme backbone. This change led to a second generation compound with increased potency, a 400-fold enhancement in aqueous solubility at pH 4, and improved dog pharmacokinetics relative to the first generation compound.
==About this Structure==
==About this Structure==
-
2G1Q is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with MG, ADP and N9H as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2G1Q OCA].
+
2G1Q is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=MG:'>MG</scene>, <scene name='pdbligand=ADP:'>ADP</scene> and <scene name='pdbligand=N9H:'>N9H</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2G1Q OCA].
==Reference==
==Reference==
Line 21: Line 20:
[[Category: ksp-inhibitor complex]]
[[Category: ksp-inhibitor complex]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 22:13:05 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:27:17 2008''

Revision as of 15:27, 21 February 2008


2g1q, resolution 2.51Å

Drag the structure with the mouse to rotate

crystal structure of KSP in complex with inhibitor 9h

Overview

Molecular modeling in combination with X-ray crystallographic information was employed to identify a region of the kinesin spindle protein (KSP) binding site not fully utilized by our first generation inhibitors. We discovered that by appending a propylamine substituent at the C5 carbon of a dihydropyrazole core, we could effectively fill this unoccupied region of space and engage in a hydrogen-bonding interaction with the enzyme backbone. This change led to a second generation compound with increased potency, a 400-fold enhancement in aqueous solubility at pH 4, and improved dog pharmacokinetics relative to the first generation compound.

About this Structure

2G1Q is a Single protein structure of sequence from Homo sapiens with , and as ligands. Full crystallographic information is available from OCA.

Reference

Kinesin spindle protein (KSP) inhibitors. Part 4: Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP., Cox CD, Torrent M, Breslin MJ, Mariano BJ, Whitman DB, Coleman PJ, Buser CA, Walsh ES, Hamilton K, Schaber MD, Lobell RB, Tao W, South VJ, Kohl NE, Yan Y, Kuo LC, Prueksaritanont T, Slaughter DE, Li C, Mahan E, Lu B, Hartman GD, Bioorg Med Chem Lett. 2006 Jun 15;16(12):3175-9. Epub 2006 Apr 5. PMID:16603356

Page seeded by OCA on Thu Feb 21 17:27:17 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools